Canopy Growth (TSX:WEED): 1 of the Best Marijuana Stocks to Buy

Canopy Growth Corp’s (TSX:WEED)(NYSE:CGC) growing operations and its deal activity make it one of the best marijuana stock to buy.

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

The marijuana space is becoming big and confusing. There are several companies in Canada and the U.S. trying to win investor confidence in this nascent industry by putting out ambitious growth plans. 

But if you’re a long-term investor and are thinking of getting some exposure to this new growth area, then I highly recommend sticking with the big players, which have durable competitive advantages and the best chances to meet your expectations.

With theme in mind, I believe Canada’s largest pot producer, Canopy Growth (TSX:WEED)(NYSE:CGC), is your best bet. Here is why.

Growing operations

Canopy is one of the few weed companies that very early amassed the size and the market share in this new industry. What positions Canopy to deliver superior returns over the long run is its market size, capacity to ramp up production, and its vast international reach.

Canopy currently operates weed-growing facilities with over 2.4 million square feet of space. The producer has been expanding its operations quickly, which will deliver the potential to manage more than five million square feet of production space by next year.

With this market power, the producer is also consolidating its position in the market where some companies are looking to exit. In a development reported by Bloomberg News, Canopy was nearing a deal to buy Acreage Holdings in what would be the first major cross-border cannabis merger.

The deal, which could be announced as soon as this week, would be a major milestone for Canopy, as it will be able to bring one of the largest U.S.-based pot firms under its umbrella. Acreage has cultivation, processing, and dispensing licences or agreements with holders in 19 states in the U.S. It also manages a chain of retail stores called The Botanist.

As part of its plan to build an extraction and manufacturing facility in the U.S., a much bigger market for both medical and recreational marijuana, Canopy acquired a hemp licence in New York State early this year.

Initiatives like this and the company’s partnership with the Constellation Brands make Canopy a formidable player in the marijuana space and more appealing to investors looking for exposure to the U.S. cannabis market.

Constellation, the maker of popular Modelo and Corona beer, raised its stake in Canopy to 37% last August after investing about US$4 billion with the option of taking majority control of the company in the future.

Bottom line

Trading around $61 a share at the time of writing, Canopy stock has already surged more than 60% this year, benefiting from its leading position in the industry and due to its growing sales, which, according its CEO, will hit $1 billion mark in 2020.

For many conservative investors, the stock may look too pricey after such a massive rally, but that perception may not be true for a company that’s in its initial stage of growth. Canopy’s smart deal activity and its position in the market suggest to me that its stock is well on track to hit an $80 mark this year.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Haris Anwar has no positions in the stocks mentioned in this report.

More on Cannabis Stocks

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why This Little-Known Cannabis Stock Could Double in 2024

This cannabis stock has already doubled this year since 52-week lows and could easily rise that much once more.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 420-Foot Pole

Down 87% from all-time highs, Cronos Group stock is a still a high-risk investment for long-term shareholders in 2024.

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth: Buy, Sell, or Hold?

Canopy Growth (TSX:WEED) stock should make a killing on U.S. expansion, but investors will need to be very patient.

Read more »

Marijuana plant and cannabis oil bottles isolated
Energy Stocks

3 Canadian Value Stocks to Buy Right Now

Undervalued Canadian stocks such as Secure Energy should be part of your shopping list in May 2024.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Here’s Why it’s Not Too Late to Buy Cronos Group Stock

The optimism about U.S. federal marijuana legalization and its anticipation are potent bullish triggers for the Canadian cannabis industry.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Canopy Growth Stock Is on a Tear: Is it a Good Buy Now? 

Canopy Growth (TSX:WEED) stock surged by 80% from news out of the U.S., but is enough there without the news…

Read more »